| [1] |
Amy CW, Joseph TF. Blood pressure in children with chronic kidney disease: lessons learned from the Chronic Kidney Disease in Children Cohort Study[J]. Pediatr Nephrol, 2020, 35(7): 1203-1209.
doi: 10.1007/s00467-019-04288-6
|
| [2] |
Parekh RS, Carroll CE, Wolfe RA, et al. Cardiovascular mortality in children and young adults with end-stage kidney disease[J]. J Pediatr, 2002, 141(2): 191-197.
doi: 10.1067/mpd.2002.125910
|
| [3] |
Brady TM, Roem J, Cox C, et al. Adiposity, sex, and cardiovascular disease risk in children with CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study[J]. Am J Kidney Dis, 2020, 76(2): 166-173.
doi: 10.1053/j.ajkd.2020.01.011
|
| [4] |
Groothoff JW, Offringa M, Grootenhuis M, et al. Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study[J]. Nephrol Dial Transplant, 2018, 33(4): 552-560.
doi: 10.1093/ndt/gfx190
|
| [5] |
Kidney Disease: Improving Global Outcomes KDIGO Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease[J]. Kidney Int, 2021, 99(3S): S1-S87.
|
| [6] |
Flynn JT, Daniels SR, Hayman LL, et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association[J]. Hypertension, 2014, 63(5): 1116-1135.
doi: 10.1161/HYP.0000000000000007
|
| [7] |
Halbach S. Practical application of ABPM in the pediatric nephrology clinic[J]. Pediatr Nephrol, 2020, 35(11): 2067-2076.
doi: 10.1007/s00467-019-04361-0
pmid: 31732802
|
| [8] |
Ku E, Mc Culloch CE, Warady BA, et al. Twenty-four-hour ambulatory blood pressure versus clinic blood pressure measurements and risk of adverse outcomes in children with CKD[J]. Clin J Am Soc Nephrol, 2018, 13(3): 422-428.
doi: 10.2215/CJN.09630917
|
| [9] |
中国高血压防治指南修订委员会. 中国高血压防治指南 2018 年修订版[J]. 心脑血管病防治, 2019, 19(1): 21.
|
| [10] |
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children: and adolescents[J]. Pediatrics, 2017, 140(3): e20171904.
doi: 10.1542/peds.2017-1904
|
| [11] |
Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: A Scientific Statement From the American Heart Association[J]. Hypertension, 2019, 73(5): e35-e66.
|
| [12] |
Warady BA, Abraham AG, Schwartz GJ, et al. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the Chronic Kidney Disease in Children (CKiD) cohort[J]. Am J Kidney Dis, 2015, 65(6): 878-88.
doi: 10.1053/j.ajkd.2015.01.008
|
| [13] |
Lurbe E, Torró I, Álvarez J, et al. Impact of ESH and AAP hypertension guidelines for children and adolescents on office and ambulatory blood pressure-based classifications[J]. J Hypertens, 2019, 37(12): 2414-2421.
doi: 10.1097/HJH.0000000000002229
|
| [14] |
Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring[J]. J Hypertens, 2008, 26(8): 1505-1526.
doi: 10.1097/HJH.0b013e328308da66
|
| [15] |
Stergiou G, Stambolliu E, Bountzona I, et al. Home blood pressure monitoring in children and adolescents: systematic review of evidence on clinical utility[J]. Curr Hypertens Rep, 2019, 21(8): 64.
doi: 10.1007/s11906-019-0967-2
pmid: 31240404
|
| [16] |
Kidney Disease: Improving Global Outcomes KDIGO Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease[J]. Kidney Int Suppl, 2012, 2(5):372-376.
|
| [17] |
ESCAPE Trial Group, Wuhl E, Trivelli A, et al. Strict blood-pressure control and progression of renal failure in children[J]. N Engl J Med, 2009, 361(17): 1639-1650.
doi: 10.1056/NEJMoa0902066
|
| [18] |
Atkinson MA, Ng DK, Warady BA, et al. The CKiD study: overview and summary of findings related to kidney disease progression[J]. Pediatr Nephrol, 2021, 36(3): 527-538.
doi: 10.1007/s00467-019-04458-6
|
| [19] |
Joseph TF, Megan KC, Derek KN, et al. Achieved clinic blood pressure level and chronic kidney disease progression in children: a report from the Chronic Kidney Disease in Children cohort[J]. Pediatr Nephrol, 2021, 36(6): 1551-1559.
doi: 10.1007/s00467-020-04833-8
pmid: 33200315
|
| [20] |
Kogon AJ, Pierce CB, Cox C, et al. Nephrotic-range proteinuria is strongly associated with poor blood pressure control in pediatric chronic kidney disease[J]. Kidney Int, 2014, 85(4): 938-944.
doi: 10.1038/ki.2013.352
pmid: 24048375
|
| [21] |
Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents[J]. J Hypertens, 2016, 34(10): 1887-920.
doi: 10.1097/HJH.0000000000001039
|
| [22] |
Alfred KC, Tara IC, William CC, et al. Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney Int, 2019, 95(5): 1027-1036.
doi: S0085-2538(19)30107-3
pmid: 31010478
|
| [23] |
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents[J]. Pediatrics, 2017, 140(3): e20171904.
doi: 10.1542/peds.2017-1904
|
| [24] |
Hari P, Sahu J, Sinha A, et al. Effect of enalapril on glomerular filtration rate and proteinuria in children with chronic kidney disease: a randomized controlled trial[J]. Indian Pediatr, 2013, 50(10): 923-928.
doi: 10.1007/s13312-013-0262-2
|
| [25] |
Seeman T, Gilik J, Vondrak K, et al. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy[J]. Am J Hypertens, 2007, 20(9): 990-996.
pmid: 17765141
|
| [26] |
Xie X, Liu Y, Perkovic V, et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials[J]. Am J Kidney Dis, 2016, 67(5): 728-741.
doi: 10.1053/j.ajkd.2015.10.011
|
| [27] |
Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney Int, 2020, 97(1): 42-61.
doi: 10.1016/j.kint.2019.09.018
|
| [28] |
Clase CM, Barzilay J, Gao P, et al. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes[J]. Kidney Int, 2017, 91(3): 683-690.
doi: 10.1016/j.kint.2016.09.038
|
| [29] |
Bandak G, Sang Y, Gasparini A, et al. Hyperkalemia after initiating renin-angiotensin system blockade: The Stockholm Creatinine Measurements (SCREAM) Project[J]. J Am Heart Assoc, 2017, 6(7): e005428.
doi: 10.1161/JAHA.116.005428
|
| [30] |
Jun M, Jardine MJ, Perkovic V, et al. Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study[J]. PLoS One, 2019, 14(3): e0213192.
doi: 10.1371/journal.pone.0213192
|
| [31] |
Ahmed AK, Kamath NS, El Kossi M, et al. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease[J]. Nephrol Dial Transplant, 2010, 25(12): 3977-3982.
doi: 10.1093/ndt/gfp511
|
| [32] |
Tobe SW, Clase CM, Gao P, et al. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies[J]. Circulation, 2011, 123(10): 1098-1107.
doi: 10.1161/CIRCULATIONAHA.110.964171
|
| [33] |
Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy[J]. N Engl J Med, 2013, 369(20): 1892-1903.
doi: 10.1056/NEJMoa1303154
|
)
沪公网安备 31011002000392号
